Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Seq of drug-treated and control 4T1 cells

ABSTRACT: RNA-Seq of drug-treated and control 4T1 cells

PROVIDER: PRJNA988540 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Profiling of differential RNAs in LY500307-treated 4T1 cells and control cells

Project description:In this study, we examined the differential RNA profile of LY500307-treated 4T1 cells compared with control-treated 4T1 cells

2018-04-25 | GSE110770 | GEO

Expression data from TKI258 treated 4T1 cells and 4T1 tumors

Project description:This SuperSeries is composed of the following subset Series: GSE19220: Expression data from TKI258 treated 4T1 cells GSE19221: Expression data from TKI258 treated 4T1 tumors Refer to individual Series

2010-07-07 | E-GEOD-19222 | biostudies-arrayexpress

Profiling of differential RNAs in LY500307-treated 4T1 cells and control cells

Project description:Profiling of differential RNAs in LY500307-treated 4T1 cells and control cells

| PRJNA434514 | ENA

Expression data from TKI258 treated 4T1 cells

Project description:4T1 mouse mammary carcinoma cells have an autocrine FGFR active loop leading to constitutive activation of downstream signaling pathways. We found that FGFR inhibitors have a strong effect on the proliferation and survival of these cells. We used microarray to understand the contribution of FGFR signaling to the tumorigenic phenotype of the 4T1 cells. 4T1 cells were grown in tissue culture and treated with TKI258 or DMSO as vehicle control for 16 hours. The RNA were extracted from three individual dishes per condition and hybridized on Affimetrix microarrays.

2010-07-07 | E-GEOD-19220 | biostudies-arrayexpress

4T1 breast cancer cells: SPARC knock down vs. Control

Project description:Comparative analysis of the transcriptome of 4T1 cells stably transduced with a lentiviral vector expressing a siRNA against murine SPARC (4T1-C18) with 4T1 control cells stably transduced with a lentiviral vector expressing a scramble sequence (4T1-SCR). Two-condition experiment, 4T1-C18 vs. 4T1-SCR cells. Biological replicates: 4 SPARC knock down, 4 control, independently grown in vitro and harvested. One replicate per array. Microarrays were hybridized in three different days.

2016-06-29 | E-GEOD-83830 | biostudies-arrayexpress

RNA-Seq of drug-treated and control 4T1 cells

Project description:Cell derived xenografts treated with DMSO, Oxa, APAP or OAP2 were collected and then the total RNA was isolated. After removal of the remaining genomic DNA, mRNA was purified from total RNA using polyT and then fragmented with 10× RNA fragmentation buffer and the RNA-seq library was constructed using Hieff NGS Ultima Dual-mode mRNA Library Prep Kit and was sequenced.

2024-06-28 | GSE236067 | GEO

4T1 breast cancer cells: SPARC knock down vs. Control

2016-06-29 | GSE83830 | GEO

RNA from 4T1 tumors in mice treated with miR-loaded EVs

Project description:RNA was harvested from 4T1 tumors in mice treated with miR-loaded EVs

2022-05-13 | GSE167753 | GEO

Label-free LC-MS/MS of Ubiquitinated proteins derived from UPs-4T1/WT and UPs-4T1/EPB nanovaccine

Project description:In this project, 4T1 parental cells (4T1/WT) were exposed to increasing concentrations of epirubicin (EPB) to establish a novel multi-drug resistant CSC-like breast cancer cell line (4T1/EPB). The ubiquitinated proteins were enriched from 4T1/WT or 4T1/EPB derived cell lysate using a-Al2O3-Vx3 nanoparticles to produce the covalently linked product UPs nanovaccine. Label-free LC-MS/MS mass spectrometry was used to detect the type and amount of enriched proteins of UPs from the 4T1/WT cells and the 4T1/EPB cells.

2021-08-20 | PXD027822 | Pride

4T1 vs. MMP3-low 4T1

Project description:Molecular comparison between control 4T1 cells with MMP3-low 4T1 cells

2015-04-22 | GSE68100 | GEO